IXC.AX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 02:20):
Our systems believe the stock currently is undervalued by 0.14% compare to its pairs and should correct upwards.

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial...

Stats
Dagens volum	445
Gjennomsnittsvolum	47 766
Markedsverdi	4.51M
EPS	$-0.0281 ( Q2 \| 2023-12-31 )
Neste inntjeningsdato	( $0 ) 2024-08-14
Last Dividend	$0.186 ( 2023-12-08 )
Next Dividend	$0 ( N/A )
P/E	-0.750 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

ACW.AX 4.84%

ADO.AX 5.00%

AGH.AX 4.35%

ANP.AX -4.92%

ATH.AX 25.00%

AVE.AX -33.33%

BIT.AX 2.63%

BNO.AX -10.00%

BOT.AX -8.70%

CAN.AX 7.14%

CPH.AX 0.00%

CSL.AX -0.88%

CTE.AX 0.81%

CUV.AX -0.65%

CYP.AX 0.00%

DXB.AX 3.92%

ECS.AX 5.88%

EOF.AX -6.67%

GSS.AX 5.56%

IDT.AX -4.55%

IMC.AX -5.68%

IMM.AX 5.08%

IMU.AX -3.51%

IXC.AX 0.00%

KZA.AX 9.59%

LCT.AX 7.14%

LGP.AX 5.26%

MSB.AX 1.01%

MVP.AX -2.47%

MXC.AX 2.44%

NEU.AX -4.98%

NOX.AX 0.00%

NSB.AX 0.00%

OCC.AX 2.82%

OPT.AX -1.43%

OSL.AX 25.00%

PAA.AX 0.00%

PAB.AX 14.29%

PAR.AX 13.73%

PBP.AX 0.00%

PIQ.AX -1.14%

PTX.AX 5.26%

PXS.AX 3.70%

PYC.AX 0.00%

RAC.AX -0.27%

RCE.AX 5.26%

SPL.AX -3.16%

TLX.AX -3.00%

VBS.AX -1.30%

Korrelasjon (AI algo v.1.1b): Undervalued: 0.14% $0.0601 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Invex Therapeutics Ltd Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Invex Therapeutics Ltd Økonomi

Annual	2023
Omsetning:	$459 085
Bruttogevinst:	$459 085 (100.00 %)
EPS:	$-0.100

FY	2023
Omsetning:	$459 085
Bruttogevinst:	$459 085 (100.00 %)
EPS:	$-0.100

FY	2022
Omsetning:	$182 251
Bruttogevinst:	$182 251 (100.00 %)
EPS:	$-0.0526

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.0407

Financial Reports:

No articles found.

Invex Therapeutics Ltd Dividends

(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.186 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Invex Therapeutics Ltd Dividend Information - Dividend Knight

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.186	2023-12-08
Last Dividend	$0.186	2023-12-08
Next Dividend	$0	N/A
Payout Date	2023-12-18
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.186	--
Avg. Dividend % Per Year	11.07%	--
Score	4.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-07-01)

$0.373 Estimate 2.50 %

Dividend Stability

0.20 Very Poor

Dividend Score

4.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2023	$0.186	33.20%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
08 Dec 2023	$0.186	30 Nov -0001	11 Dec 2023	18 Dec 2023

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
EZL.AX	Dividend Royal	2024-02-02	Semi-Annually	24	11.64%	8.24
GRR.AX	Dividend Royal	2024-03-12	Semi-Annually	14	11.88%	7.99
RKN.AX	Dividend Royal	2023-08-31	Annually	22	15.73%	7.24
TWR.AX	Dividend King	2024-06-12	Annually	25	5.98%	7.21
YAL.AX	Dividend Royal	2024-03-12	Annually	7	12.76%	7.18
SHM.AX	Dividend Royal	2024-03-14	Semi-Annually	9	14.97%	7.14
HZN.AX	Dividend Royal	2024-04-18	Semi-Annually	4	18.99%	7.06
BHP.AX	Dividend Royal	2024-03-07	Semi-Annually	37	6.46%	6.97
CDD.AX	Ex Dividend King	2024-05-24	Annually	21	91.43%	6.79
KSL.AX	Dividend Royal	2024-03-05	Semi-Annually	9	9.58%	6.77

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-10.40	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-1.881	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.674	1.500	-8.60	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	6.38	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	6.38	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	6.25	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.142	2.00	-0.0473	-0.0946	[0 - 30]
freeCashFlowPerShareTTM	-0.142	2.00	-0.0709	-0.142	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.339	1.000	7.69	7.69	[0.2 - 0.8]
operatingProfitMarginTTM	-11.84	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.181	0.800	-2.13	-1.702	[0.5 - 2]
Total Score				-1.447

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.382	1.000	-0.140	0	[1 - 100]
returnOnEquityTTM	-0.674	2.50	-5.53	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.142	2.00	-0.0473	-0.142	[0 - 30]
dividendYielPercentageTTM	310.50	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.142	2.00	-0.0473	-0.0946	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0153	1.500	-3.44	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-9.39	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-1.548

Invex Therapeutics Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Invex Therapeutics Ltd